OTC Markets OTCPK - Delayed Quote USD

ProText Mobility, Inc. (TXTM)

0.0007
0.0000
(0.00%)
At close: 3:54:57 PM EDT

Key Executives

Amounts are as of -- and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.
NameTitlePayExercisedYear Born
Mr. Roger Baylis-Duffield Chairman, President & CEO -- -- 1943

ProText Mobility, Inc.

One West Las Olas Blvd.
Suite 500
Fort Lauderdale, FL 33301
United States
https://www.protxtm.com
Sector: 
Healthcare
Industry: 
Biotechnology

Description

ProText Mobility, Inc., a biotech company, engages in the development of pharmaceutical botanical medicines. Its medicines are formulated with highly-bioavailable plant extracts. The company is based in Fort Lauderdale, Florida. ProText Mobility, Inc. operates as a subsidiary of Plandaí Biotechnology, Inc.

Corporate Governance

ProText Mobility, Inc.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.
Corporate governance scores courtesy of Institutional Shareholder Services (ISS) Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.

Upcoming Events

Recent Events

Related Tickers

WPDPF WPD Pharmaceuticals Inc.
0.0000
0.00%
 
RGBPP Regen BioPharma, Inc.
0.0521
0.00%
 
FNCH Finch Therapeutics Group, Inc.
13.17
+1.31%
 
ADAG Adagene Inc.
1.7200
+1.18%
 
FBIOP Fortress Biotech, Inc.
6.18
-2.52%
 
TSOI Therapeutic Solutions International, Inc.
0.0001
0.00%
 
RGBP Regen BioPharma, Inc.
0.0640
+10.14%
 
XCUR Exicure, Inc.
11.40
-3.88%
 
TRAW Traws Pharma, Inc.
1.2200
-12.23%
 
PYPD PolyPid Ltd.
2.7100
-4.91%